Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective
- PMID: 22337235
- DOI: 10.3899/jrheum.110818
Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective
Abstract
Objective: To determine the timeliness of consultation and initiation of disease-modifying antirheumatic drugs (DMARD) in patients with rheumatoid arthritis (RA) referred to rheumatologists.
Methods: The first part of the study was a review of the charts of 151 patients with RA followed by 3 rheumatologists. The outcome measure was the interval between symptom onset and consultation with a rheumatologist. The second part of the study involved a chart review of 4 family physician practices in a small urban center in order to determine the accuracy of diagnostic coding (International Classification of Diseases; ICD-9) of RA, as well as the proportion of patients with RA seen by a rheumatologist. Finally, a survey was sent to primary care physicians at a group of walk-in clinics to determine what percentage of their patients with RA were referred to a rheumatologist and, concerning referral patterns, how likely it is they would refer a confirmed or suspected RA patient to a rheumatologist.
Results: Patients with RA referred to rheumatologists in this sample were seen by a rheumatologist at a mean of 9.8 months (median 5 mo, range 0-129 mo) after symptom onset, and mean 1.2 months (median 4.0 mo, range 0-8 mo) after being referred by their primary care physician. All referred patients with confirmed RA were started on DMARD within 1 week of initial consultation. Primary care physicians would refer suspected RA patients 99.5% of the time (median 100, range 90-100%), and 87.6% (median 90, range 50-100%) of patients with confirmed RA would have seen a rheumatologist at least once. A chart review showed that, in a select group of family physicians, 70.9% (22/31) of patients coded as RA per the ICD-9 did indeed have RA and all had seen a rheumatologist for their condition.
Conclusion: In Northern Alberta, patients with RA are seen and started on DMARD therapy in a timely fashion. Most of the delay is at the primary care level, suggesting a need for improved education of patients and primary care physicians rather than a formal triage system.
Similar articles
-
Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city.J Rheumatol. 2011 Jul;38(7):1282-8. doi: 10.3899/jrheum.101315. Epub 2011 May 15. J Rheumatol. 2011. PMID: 21572157
-
Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).Rheumatology (Oxford). 2009 Jun;48(6):650-7. doi: 10.1093/rheumatology/kep045. Epub 2009 Mar 25. Rheumatology (Oxford). 2009. PMID: 19321515
-
Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.J Rheumatol. 2000 Oct;27(10):2323-8. J Rheumatol. 2000. PMID: 11036824
-
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.Clin Ther. 2009 Aug;31(8):1737-46. doi: 10.1016/j.clinthera.2009.08.009. Clin Ther. 2009. PMID: 19808132 Review.
-
Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.J Clin Rheumatol. 2009 Jun;15(4):203-10. doi: 10.1097/RHU.0b013e3181a90cd8. J Clin Rheumatol. 2009. PMID: 19502907 Review.
Cited by
-
The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologist.Rheumatol Adv Pract. 2019 Aug 30;3(2):rkz035. doi: 10.1093/rap/rkz035. eCollection 2019. Rheumatol Adv Pract. 2019. PMID: 32083241 Free PMC article.
-
Factors associated with time to diagnosis in early rheumatoid arthritis.Rheumatol Int. 2014 Jan;34(1):85-92. doi: 10.1007/s00296-013-2846-5. Epub 2013 Aug 30. Rheumatol Int. 2014. PMID: 23989941
-
The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms.Open Access Rheumatol. 2017 Jul 28;9:139-150. doi: 10.2147/OARRR.S138830. eCollection 2017. Open Access Rheumatol. 2017. PMID: 28814904 Free PMC article. Review.
-
Effectiveness of General Medicine in the Management of Rheumatoid Arthritis in Rural Settings: A Systematic Review and Meta-Ethnography.Cureus. 2024 Nov 15;16(11):e73726. doi: 10.7759/cureus.73726. eCollection 2024 Nov. Cureus. 2024. PMID: 39677127 Free PMC article. Review.
-
A scoping review of triage approaches for the referral of patients with suspected inflammatory arthritis, from primary to rheumatology care.Rheumatol Int. 2024 Nov;44(11):2279-2292. doi: 10.1007/s00296-024-05575-8. Epub 2024 Mar 26. Rheumatol Int. 2024. PMID: 38530455
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical